China Shineway Pharmaceutical Group Limited (HKG:2877)
Hong Kong
· Delayed Price · Currency is HKD 9.85
+0.07 (0.72%)
Apr 29, 2026, 4:08 PM HKT
HKG:2877 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 949.95 | 840.05 | 969.51 | 722.77 | 556.67 | Upgrade
|
| Depreciation & Amortization | 70.88 | 68.74 | 60.23 | 185.86 | 182.39 | Upgrade
|
| Loss (Gain) From Sale of Assets | -4.83 | -4.01 | 2.39 | -0.13 | 16.47 | Upgrade
|
| Loss (Gain) From Sale of Investments | 35.74 | 6.61 | 5.44 | 8.83 | 7.02 | Upgrade
|
| Stock-Based Compensation | - | - | - | - | 0.03 | Upgrade
|
| Other Operating Activities | -382.23 | -170.21 | -128.19 | -97.6 | -102.65 | Upgrade
|
| Change in Accounts Receivable | 166.06 | 51.76 | -290.75 | -158.71 | -66.97 | Upgrade
|
| Change in Inventory | 182.06 | 169.97 | -123.18 | -69.7 | -140.13 | Upgrade
|
| Change in Accounts Payable | -62.94 | -80.12 | 176.05 | 80.13 | 55.39 | Upgrade
|
| Change in Unearned Revenue | 121.57 | -25.12 | -101.56 | 67.23 | 18.21 | Upgrade
|
| Change in Other Net Operating Assets | 95.78 | 105.47 | 362.69 | 370.99 | 176.71 | Upgrade
|
| Operating Cash Flow | 1,172 | 963.14 | 932.64 | 1,110 | 703.15 | Upgrade
|
| Operating Cash Flow Growth | 21.69% | 3.27% | -15.95% | 57.82% | 10.11% | Upgrade
|
| Capital Expenditures | -197.91 | -140.11 | -144.33 | -129.46 | -93.63 | Upgrade
|
| Sale of Property, Plant & Equipment | 14.66 | 4.71 | 12.9 | 2.58 | 81.6 | Upgrade
|
| Cash Acquisitions | - | - | - | - | 8.51 | Upgrade
|
| Divestitures | - | 2.34 | - | 0.92 | 0.88 | Upgrade
|
| Investment in Securities | 150.33 | -337.38 | 10.31 | 6.67 | 8.74 | Upgrade
|
| Other Investing Activities | 254.94 | 198.34 | 71.58 | 73.88 | 388.92 | Upgrade
|
| Investing Cash Flow | 222.03 | -272.11 | -49.54 | -45.42 | 395.01 | Upgrade
|
| Short-Term Debt Issued | 325.05 | 330 | 300 | - | - | Upgrade
|
| Total Debt Issued | 325.05 | 330 | 300 | - | - | Upgrade
|
| Short-Term Debt Repaid | -330 | -300 | - | - | -370.32 | Upgrade
|
| Long-Term Debt Repaid | -9.34 | -8.29 | -6.88 | -7.68 | -7.71 | Upgrade
|
| Total Debt Repaid | -339.34 | -308.29 | -6.88 | -7.68 | -378.03 | Upgrade
|
| Net Debt Issued (Repaid) | -14.29 | 21.71 | 293.13 | -7.68 | -378.03 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 3.66 | Upgrade
|
| Common Dividends Paid | -355.04 | -407.92 | -317.27 | -241.73 | -453.07 | Upgrade
|
| Other Financing Activities | -5.69 | -6.27 | -2.6 | -0.63 | -1.49 | Upgrade
|
| Financing Cash Flow | -375.01 | -392.48 | -26.74 | -250.04 | -828.94 | Upgrade
|
| Foreign Exchange Rate Adjustments | 29.84 | -47.17 | 6.15 | 6.33 | -6.51 | Upgrade
|
| Net Cash Flow | 1,049 | 251.38 | 862.51 | 820.54 | 262.71 | Upgrade
|
| Free Cash Flow | 974.13 | 823.02 | 788.31 | 980.21 | 609.52 | Upgrade
|
| Free Cash Flow Growth | 18.36% | 4.40% | -19.58% | 60.82% | 6.46% | Upgrade
|
| Free Cash Flow Margin | 31.07% | 21.78% | 17.45% | 24.81% | 18.91% | Upgrade
|
| Free Cash Flow Per Share | 1.29 | 1.09 | 1.04 | 1.30 | 0.81 | Upgrade
|
| Cash Interest Paid | 5.69 | 6.27 | 2.6 | 0.63 | 1.49 | Upgrade
|
| Cash Income Tax Paid | 217.96 | 246.4 | 224.14 | 136.3 | 132.32 | Upgrade
|
| Levered Free Cash Flow | 731.25 | 564.33 | 484.47 | 827.13 | 776.83 | Upgrade
|
| Unlevered Free Cash Flow | 734.8 | 568.16 | 486.18 | 827.52 | 777.61 | Upgrade
|
| Change in Working Capital | 502.52 | 221.96 | 23.25 | 289.94 | 43.21 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.